Procedure for quantitative 1H magnetic resonance spectroscopy and tissue characterization of human brain tissue based on the use of quantitative magnetic resonance imaging

Existing methods for quantitative magnetic resonance spectroscopy are not widely used for magnetic resonance spectroscopy examinations in clinical practice due to the lengthy and difficult workflow. In this report, we aimed to investigate whether metabolite concentrations show co‐variation with relaxation parameters (R1,H2O,R2,H2O), water concentration (ĈH2O), and age, using a quantitative magnetic resonance spectroscopy method, which is suitable for a clinical setting.

[1]  Zografos Caramanos,et al.  1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. , 2005, Brain : a journal of neurology.

[2]  P. Lundberg,et al.  Rapid magnetic resonance quantification on the brain: Optimization for clinical usage , 2008, Magnetic resonance in medicine.

[3]  A. Mackay,et al.  Absolute metabolite concentrations calibrated using the total water signal in brain 1H MRS , 2009, NMR in biomedicine.

[4]  D. Hoult.  The principle of reciprocity in signal strength calculations—a mathematical guide , 2000 .

[5]  R. Kreis.  Issues of spectral quality in clinical 1H‐magnetic resonance spectroscopy and a gallery of artifacts , 2004, NMR in biomedicine.

[6]  A. Thompson,et al.  Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.

[7]  N. Gelman,et al.  Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: Relation to estimated iron and water contents , 2001, Magnetic resonance in medicine.

[8]  R. Tarducci,et al.  Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. , 1999, Brain : a journal of neurology.

[9]  G Helms,et al.  A precise and user‐independent quantification technique for regional comparison of single volume proton MR spectroscopy of the human brain , 2000, NMR in biomedicine.

[10]  G Johnson,et al.  Precise relaxation time measurements of normal‐appearing white matter in inflammatory central nervous system disease , 1989, Magnetic resonance in medicine.

[11]  P. Lundberg,et al.  Novel whole brain segmentation and volume estimation using quantitative MRI , 2012, European Radiology.

[12]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .

[13]  G. B. Pike,et al.  Characterizing healthy and diseased white matter using quantitative magnetization transfer and multicomponent T2 relaxometry: A unified view via a four‐pool model , 2009, Magnetic resonance in medicine.

[14]  J. Frahm,et al.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.

[15]  J. Frahm,et al.  Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.

[16]  P. Lundberg,et al.  Low Choline Concentrations in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans , 2007, American Journal of Neuroradiology.

[17]  Geoff J. M. Parker,et al.  1H Magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis , 1999, Journal of Neurology.

[18]  C. Laule,et al.  Water content and myelin water fraction in multiple sclerosis , 2004, Journal of Neurology.

[19]  Nadim Joni Shah,et al.  Fast quantitative mapping of absolute water content with full brain coverage , 2008, NeuroImage.

[20]  Ralf Deichmann,et al.  Fast high‐resolution T1 mapping of the human brain , 2005, Magnetic resonance in medicine.

[21]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations , 1993 .

[22]  G. Barker,et al.  Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis , 1999, Journal of the Neurological Sciences.

[23]  C F Hazlewood,et al.  Nuclear magnetic resonance transverse relaxation times of water protons in skeletal muscle. , 1974, Biophysical journal.

[24]  Oded Gonen,et al.  Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. , 2003, Magnetic resonance imaging.

[25]  D. Arnold,et al.  1 H-MRS quantification of tNA and tCr in patients with multiple sclerosis : a meta-analytic review , 2005 .

[26]  Peter Kapeller,et al.  Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study , 2001, Journal of Neurology.

[27]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[28]  B. Rutt,et al.  Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state , 2003, Magnetic resonance in medicine.

[29]  C H Polman,et al.  MR spectroscopic evidence for glial increase but not for neuro‐axonal damage in MS normal‐appearing white matter , 2005, Magnetic resonance in medicine.

[30]  Peter Mattsson,et al.  Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1h magnetic resonance spectroscopy (MRS) study , 2010, Acta radiologica.

[31]  O Henriksen,et al.  Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites , 1994, NMR in biomedicine.

[32]  Joanna M. Wardlaw,et al.  A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging , 2009, Neurobiology of Aging.